<< Back To Search

Study of CART-ddBMCA in Relapsed or Refractory Multiple Myeloma (iMMagine-1)

Notify the Multiple Myeloma Research Foundation You Are Interested In This Trial


Third Opinion Trial Synopsis:
This study is testing a new treatment called CART-ddBCMA for people who have multiple myeloma and it has come back after treatment or is not responding to treatment. CART-ddBCMA is a type of therapy that uses special cells to fight the cancer.
*Third Opinion AI Generated Synopsis

Trial Summary
A Phase II study of CART-ddBCMA for patients with relapsed or refractory multiple myeloma. CART-ddBCMA is a BCMA-directed CAR-T cell therapy

Locations & Contact

Fill out the form and "Notify Multiple Myeloma Research Foundation" to let the Multiple Myeloma Research Foundation know you are interested in this trial.

Please share any additional considerations or concerns:
Example: Are you newly diagnosed? What treatments have you already been on?